Journal article icon

Journal article

The new immunosuppression.

Abstract:
New knowledge on how lymphocytes become tolerant to antigens is now enabling novel tolerance-harnessing strategies to enter the clinical arena. In the field of transplantation, monoclonal antibodies used either to deplete lymphocytes or to block T-cell function can induce tolerance in mice and non-human primates. Understanding the mechanisms underlying tolerance should enable application to the clinic. Harnessing of tolerance mechanisms may enable more judicious use of conventional immunosuppressive agents even to the point of maintenance monotherapy, so limiting drug side effects and ensuring compliance.
Publication status:
Published

Actions

Access Document

Publisher copy:
10.1016/s1367-5931(03)00076-0

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pathology Dunn School
Role:
Author


Journal:
Current opinion in chemical biology More from this journal
Volume:
7
Issue:
4
Pages:
476-480
Publication date:
2003-08-01
DOI:
EISSN:
1879-0402
ISSN:
1367-5931


Language:
English
Keywords:
Pubs id:
pubs:16954
UUID:
uuid:11d8e59d-b3b3-4a78-be7c-e076068abd92
Local pid:
pubs:16954
Source identifiers:
16954
Deposit date:
2012-12-19
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP